Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 30B acts as an accessory beta subunit necessary for the function of P4-ATPase flippase complexes, which maintain the asymmetric distribution of aminophospholipids (like phosphatidylserine and phosphatidylethanolamine) across cell membranes. TMEM30B facilitates the transport of P4-ATPase alpha subunits from the endoplasmic reticulum to the plasma membrane and is involved in processes such as protein exit from the ER, vesicle formation, and uptake of lipid signaling molecules. Its expression levels and genetic alterations are associated with specific disease states, particularly in cancer where downregulation or deletion has prognostic significance. TMEM30B is distinct from TMEM30A and localizes mainly to the endoplasmic reticulum, with both protein termini exposed to the cytoplasm. Dysfunction or aberrant expression of TMEM30B may impact phospholipid asymmetry, cellular apoptosis, and potentially contribute to the etiology and progression of certain tumors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 30B (TMEM30B).